Evidence map›Paper›PMID 40149350›Full record

ArticleCancers2025

Predictors and Drivers of End-of-Life Medicare Spending Among Older Adults with Solid Tumors: A Population-Based Study.

Courtney E Baird, Elizabeth Wulff-Burchfield, Pamela C Egan, Lee A Hugar, Ami Vyas, Nikolaos A Trikalinos, Michael A Liu, Adam J Olszewski, Leonidas E Bantis, Orestis A Panagiotou and 1 more

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Courtney E BairdCenter for Gerontology and Healthcare Research, Department of Health Services, Policy and Practice, Brown University School of Public Health, Providence, RI 02903, USA.ORCID 0000-0002-2841-9183
Elizabeth Wulff-BurchfieldMedical Oncology Division and Palliative Medicine Division, Department of Internal Medicine, University of Kansas School of Medicine, University of Kansas Cancer Center, The University of Kansas Health System, Kansas City, KS 66160, USA.ORCID 0000-0003-1474-7095
Pamela C EganDepartment of Medicine, The Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
Lee A HugarDepartment of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
Ami VyasDepartment of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.
Nikolaos A TrikalinosDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0001-8611-2182
Michael A LiuHerbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY 10032, USA.ORCID 0000-0001-9629-9331
Adam J OlszewskiDepartment of Medicine, The Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.ORCID 0000-0002-6472-6658
Leonidas E BantisDepartment of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Orestis A PanagiotouCenter for Gerontology and Healthcare Research, Department of Health Services, Policy and Practice, Brown University School of Public Health, Providence, RI 02903, USA.
Emmanuelle BélangerCenter for Gerontology and Healthcare Research, Department of Health Services, Policy and Practice, Brown University School of Public Health, Providence, RI 02903, USA.

Funding

RADx-UP: Improving the Response of Local Urban and Rural Communities to Disparities in Covid-19 TestingUL1TR002366 · NCATS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Mario Castro, JAMES STEVEN LEEDER · 2017 to 2026
$44.3M
Molecular Oncology Training ProgramT32CA203703 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Katherine D Crew, DAWN HERSHMAN · 2016 to 2026
$4.1M
Leukemia and Lymphoma Society CDP-2339-22NCATS NIH HHS UL1 TR002366NCATS NIH HHS UL1TR002366NCI NIH HHS HHSN261201800009CNCI NIH HHS HHSN261201800009INCI NIH HHS HHSN261201800015CNCI NIH HHS HHSN261201800015INCI NIH HHS HHSN261201800032CNCI NIH HHS HHSN261201800032INCI NIH HHS T32 CA203703
6 · The paper itself

Abstract

High-intensity end-of-life (EoL) care for patients with cancer often includes multiple transitions to the hospital and intensive care unit (ICU) and is associated with adverse outcomes, such as declines in patient functional abilities [...].

Indexed as

cancerend-of-life caregeriatric oncologyMedicare spendingpalliative care

Identifiers

PMID40149350
PMCPMC11941710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.